Benjamin Edwards Inc. reduced its holdings in Wells Fargo & Company by 28.8% in the second quarter, selling 15,899 shares, but still holds 39,388 shares valued at $3.255 million. Meanwhile, other institutional investors like Norges Bank and Amundi increased their stakes in WFC. Analysts …
Aurora Investment Counsel has acquired a new stake of 26,890 shares in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) during the second quarter, valued at approximately $2.23 million. This comes as several other institutional investors have also adjusted their holdings in the specialty pharmaceutical company. ANI Pharmaceuticals …
Abacus FCF Advisors LLC has acquired a new position of 103,898 shares in Archer Daniels Midland Company (NYSE:ADM), valued at approximately $7.94 million, making it their 29th largest holding. Several other institutional investors also adjusted their stakes in ADM. The article details ADM's recent …
Aurinia Pharmaceuticals Inc. recently reported second-quarter 2026 results showing higher revenue and earnings year over year, reiterated its 2026 revenue and net product sales guidance, completed a large share buyback program, and finalized a settlement with Teva Pharmaceuticals that delays U.S. generic voclosporin entry …
Applied Materials reported strong Q2 results, exceeding revenue and profitability estimates, driven by robust demand for semiconductor manufacturing equipment. Despite the positive performance and increased guidance for Q3, the market reacted negatively. The article highlights key analyst questions from the earnings call, focusing on …
AMAT
main company
AMAT
main company
A1MT34
main company
AMAT
main company
AMAT
main company
AP2
main company
Precious metals stocks, including Wheaton Precious Metals (WPM), rallied sharply due to a U.S. Treasury Department announcement to expand long-term bond buybacks, which decreased bond yields and increased the appeal of non-yielding assets like gold. Wheaton Precious Metals, a metal streaming company, saw its …
Thirteen research firms have given Syndax Pharmaceuticals (NASDAQ:SNDX) an average recommendation of "Moderate Buy," with an average 12-month price target of $41.91. Despite missing Q2 earnings and revenue estimates and insider share sales, institutional investors like BlackRock and Vanguard have increased their stakes. The …
Phio Pharmaceuticals (PHIO) Chairman Robert Bitterman has purchased an additional 10,000 shares of the company, bringing his total holdings to 431,421 shares. This transaction at $1.06 per share reflects a strong insider sentiment, with 6 insider buys and 0 insider sells over the past …
Intercontinental Hotels Group (NYSE:IHG) shares have surpassed their 200-day moving average, trading at $161.5050 after reaching a high of $163.00. The stock maintains a "Moderate Buy" consensus rating with an average price target of $174.50, despite mixed analyst views including a recent downgrade to …
Shares of Huntington Ingalls Industries Inc. (HII) fell by 3.32% on Thursday, closing at $301.40. This decline occurred during a broader market downturn, with the S&P 500 Index and Dow Jones Industrial Average also experiencing losses. This marks the fourth consecutive day of losses …
Applied Materials (AMAT) reported a record fiscal third quarter with revenue up 25% year-over-year and EPS up 41%, exceeding analyst expectations. Despite strong performance and an optimistic outlook driven by AI demand, the stock fell over 3% after-hours, likely due to its "priced for …
AMAT
main company
AMAT
main company
A1MT34
main company
AMAT
main company
AMAT
main company
AP2
main company
In August 2026, Regeneron Pharmaceuticals announced that the US FDA approved Pasatru (garetosmab-grts) to reduce new heterotopic ossification lesions and flare-ups in adults with fibrodysplasia ossificans progressiva, based on positive Phase 3 OPTIMA trial results. This approval adds a rare-disease monoclonal antibody to Regeneron's …
REGN
main company
REGN34
main company
REGN
main company
RGO
main company
REGN
main company
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Air Products and Chemicals has delivered a 27.8% total return over the past five …
APD
main company
AP3
main company
APCD
main company
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Regeneron Pharmaceuticals stock has delivered a 43.0% return over the past year, yet the …
REGN
main company
REGN34
main company
REGN
main company
RGO
main company
REGN
main company
A Mirum Pharmaceuticals officer recently sold common stock valued at approximately $4 million. This transaction indicates a significant insider sale at the company.
Search by ticker symbol or company name and select a result to open its chart.
Sharemaestro
Send a message
Ask a question, report a correction, or send a publisher/support note.
Cookie preferences
Essential cookies keep Sharemaestro secure and working. Choose whether we may use optional persistent analytics and advertising technologies. Limited cookieless server measurement continues for aggregate traffic and security.